Why is clinical validity considered the highest and most desirable level for a diagnosis to remain in the NANDA-I classification?

Clinical validity is considered the highest and most desirable level because it produces evidence about how a diagnosis actually functions in clinical practice, such as its applicability to real populations, the accuracy of its defining characteristics for diagnostic inference, screening, differentiation, prognosis, and the factors that contribute to its occurrence. This level has the most subdivisions and requires that content validation has already been completed, ensuring the diagnosis is tested against real clinical use before being retained in the classification.

According to the source, Level 2.3, clinical validity, is described as the highest and most desirable level for a diagnosis to remain in the NANDA-I classification. The reasoning is tied to the fact that this level examines the diagnosis in actual clinical practice, rather than only through expert opinion about its content. Clinical validity studies establish whether the diagnosis can be correctly identified in patient populations, how well its defining characteristics support accurate diagnostic inference, and how the diagnosis relates to causal or contributing factors. The evidence hierarchy within clinical validity includes descriptive studies that identify applicable populations, studies that assess the diagnostic accuracy and screening utility of defining characteristics, studies that differentiate similar diagnoses or predict clinical deterioration, and studies that validate related and risk factors. Because these processes verify the real-world usefulness and clinical meaning of a diagnosis, achieving clinical validity is seen as the strongest justification for keeping a diagnosis in the classification.